2001
DOI: 10.1182/blood.v97.6.1845
|View full text |Cite
|
Sign up to set email alerts
|

Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances

Abstract: IntroductionHodgkin disease (HD), one of the most common malignant lymphomas in the western world, was first described by Thomas Hodgkin in 1832. The characteristic morphologic feature of HD is the cellular composition of the tumor tissue containing a small number (approximately 0.1% to 1%) of neoplastic ReedSternberg (RS) cells and a major population of nonneoplastic lymphocytes, histiocytes, neutrophils, fibroblasts, eosinophils, and plasma cells. On the basis of tumor cell morphology, immunophenotype, and t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
45
3
2

Year Published

2002
2002
2013
2013

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 74 publications
(51 citation statements)
references
References 57 publications
(60 reference statements)
1
45
3
2
Order By: Relevance
“…The gene is rearranged in about 30% of diffuse large B cell lymphoma (DLBCL) and in 8 to 15% of follicle center lymphomas (FCL), [9][10][11] but also less frequently in other lymphoma subtypes including nodal and extra-nodal marginal zone lymphoma (MZL), 12,13 or lymphocyte predominant Hodgkin's disease (HD). 14 Immunoglobulin gene (Ig) loci are the most frequently involved partners, 15 but several other non-Ig gene partners have also been characterized, including the small G protein TTF (4p11), 16 the B cell transcriptional coactivator BOB1 (11q23), 17 the Ikaros gene (7p12), 18 or the splicing factor SRP20 (6p21). 19 In almost all cases, breakpoints are located in the 5Ј extremity of the first intron and the rearrangement conducts to substitute BCL-6 regulatory regions with those of the partner, keeping the coding region intact in all cases.…”
Section: Introductionmentioning
confidence: 99%
“…The gene is rearranged in about 30% of diffuse large B cell lymphoma (DLBCL) and in 8 to 15% of follicle center lymphomas (FCL), [9][10][11] but also less frequently in other lymphoma subtypes including nodal and extra-nodal marginal zone lymphoma (MZL), 12,13 or lymphocyte predominant Hodgkin's disease (HD). 14 Immunoglobulin gene (Ig) loci are the most frequently involved partners, 15 but several other non-Ig gene partners have also been characterized, including the small G protein TTF (4p11), 16 the B cell transcriptional coactivator BOB1 (11q23), 17 the Ikaros gene (7p12), 18 or the splicing factor SRP20 (6p21). 19 In almost all cases, breakpoints are located in the 5Ј extremity of the first intron and the rearrangement conducts to substitute BCL-6 regulatory regions with those of the partner, keeping the coding region intact in all cases.…”
Section: Introductionmentioning
confidence: 99%
“…To date, for the same reasons the cytogenetic characterization of NLPHL remains partial, limited to some CGH data, 4 to a partial analysis using interphase FISH with probes exploring genes usually involved in B-cell lymphoma 3 and to conventional cytogenetics data from a few number of patients with NLPHL or transformed lymphoma, reported together with extensive FISH and molecular analysis. 6 Our study, where the only significant imbalances involved chromosomes 1, 4, 7, 9 and 13, does not confirm the results obtained using CGH by Franke.…”
Section: Letters To the Editormentioning
confidence: 99%
“…Cytogenetic characteristics of NLPHL have been rarely reported, and were mainly obtained using molecular cytogenetic methods like fluorescent in situ hybridization (FISH) or comparative genomic hybridization (CGH). 3,4 Between 1979 and 2004, 22 patients referred to the Centre Henri Becquerel had a diagnosis of NLPHL. A single lymph node biopsy was used for morphologic, immunologic, molecular and cytogenetic studies, including molecular cytogenetics.…”
mentioning
confidence: 99%
“…25 CGH from microdissected CD20 þ malignant cells showed recurrent genomic imbalances (average 10.8 per case), involving all chromosomes including 1, 2q, 3, 4q, 5q, 6, 8q, 11q, 12q and X, and loss of chromosome 17, in 36.8-68.4% of the cases. 29 Gains of 2q, 4q, 5q, 6 and 11q are uncommon in NHL. There were frequent gains of chromosome 6q, a region often deleted in NHL.…”
Section: Nodular Lymphocyte Predominant Hlmentioning
confidence: 99%
“…29,33 Both have rearranged, mutated IGH genes with ongoing mutations. Partial gain of 4q, a rare change in lymphoma, is frequent in both.…”
Section: Nodular Lymphocyte Predominant Hlmentioning
confidence: 99%